Johnson & Johnson (JNJ) begins on Tuesday its third attempt to push through a multi-billion-dollar settlement relating to ...
Johnson & Johnson is relaunching sales of a promising heart-rhythm device after a safety scare, but with a new warning for doctors that analysts say could hamper its market potential ...
14d
Barchart on MSNJohnson & Johnson Stock Outlook: Is Wall Street Bullish or Bearish?New Brunswick, New Jersey-based Johnson & Johnson (JNJ) researches, develops, manufactures, and sells various products in the healthcare field. Valued at a market cap of $366.3 billion, the company ...
Pharmaceutical giant Johnson & Johnson (JNJ) is planning to sell its stroke care business called “Cerenovus” for $1 billion ...
Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to ...
Medical-technology and drug company's 2025 sales outlook is below consensus Johnson & Johnson's stock ... from Dow Jones Newswires and The Wall Street Journal. We sell different types of products ...
Buckhead Capital Management LLC trimmed its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 3.0% in the fourth ...
Chevy Chase Trust Holdings LLC lowered its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 5.3% during the ...
Pharmaceutical giants Johnson & Johnson and Sanofi have stopped a late-stage clinical trial for their experimental E.coli vaccine after results failed to demonstrate sufficient efficacy.
New Brunswick, New Jersey-based Johnson & Johnson (JNJ ... s earnings surprise history is promising. It surpassed the Wall Street estimates in each of the last four quarters.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results